60 degrees pharmaceuticals announces closing of initial public offering

Washington, july 14, 2023 (globe newswire) -- 60 degrees pharmaceuticals , inc., (nasdaq: sxtp; sxtpw) (“60p” or the “company”), specialists in developing and marketing medicines for infectious diseases, announced today the closing of its initial public offering of 1,415,095 units (each, a “unit,” collectively, the “units”) at a price of $5.30 per unit for a total of approximately $7.5 million of gross proceeds to the company, prior to deducting underwriting discounts, commissions and offering expenses. each unit is comprised of one share of the company's common stock, one tradeable warrant (each, a “tradeable warrant,” collectively, the “tradeable warrants”) to purchase one share of common stock at an exercise price of $6.095 per share, and one non-tradeable warrant (each, a “non-tradeable warrant,” collectively, the “non-tradeable warrants”; together with the tradeable warrants, the “warrants”) to purchase one share of the company's common stock at an exercise price of $6.36.
SXTP Ratings Summary
SXTP Quant Ranking